Regulations.gov document
2021-000930 - Tianjin Zhongxin Pharmaceutical Group Corp. Ltd- Great Wall Brand, Wuji…
Other · FDA-2021-S-0024 · posted Dec 8, 2021
Key facts
| Document ID | FDA-2021-S-0024-0610 |
|---|---|
| Title | 2021-000930 - Tianjin Zhongxin Pharmaceutical Group Corp. Ltd- Great Wall Brand, Wuji Baifeng Wan Herbal Supplement- Supports the general health of the body and helps maintain energy levels |
| Document type | Other |
| Subtype | 30 Day Structured Function Claim |
| Agency | FDA |
| Docket | FDA-2021-S-0024 |
| Posted | Dec 8, 2021 |
| Comment period opens | Dec 8, 2021 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: